This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
This page refreshes automatically every 30 mins. Press F5 to update manually
For a more detailed explanation of Upgrades/Downgrades see Link
Key: (?) = Upgraded, (?) = Downgraded, (-) = Maintained
| Stock | Broker Update |
| A.P.R. Energy | Jefferies cuts TP to 1250p from 1260p, Buy |
| African Barrick Gold | HSBC ups to neutral from underweight; TP to 230p from 160p |
| AstraZeneca | Morgan Stanley ups TP to 3800p from 3700p, Equalweight |
| Aviva | Morgan Stanley ups TP to 517p from 514p, overweight |
| DAMAC Real Estate Development | Citigroup initiates with a Buy rating |
| G4S | Panmure downgrades to sell from Hold |
| Hikma Pharmaceuticals | HSBC ups TP to 1300p from 1035p, neutral |
| Hyder | Liberum downgrades to Hold from Buy; TP to 520p from 630p |
| Inchcape | UBS cuts TP to 605p from 615p, neutral |
| Inchcape | Nomura cuts TP to 580p from 600p, neutral |
| Pace | Barclays ups to overweight from Equalweight; TP to 450p from 320p |
| Premier Oil | UBS downgrades to neutral from Buy; TP to 315p from 350p |
| Smith & Nephew | SocGen cuts TP to 630p from 660p, sell |
| Tui Travel | Nomura ups TP to 440p from 310p, neutral |
| Source: Reuters News, AlphaTerminal, Dow Jones Newswires | |
Source: Bloomberg, Reuters News, AlphaTerminal, Dow Jones Newswires
T111his research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance. Prepared by Michael van Dulken, Head of Research